A total of 839 GGN-like lung adenocarcinoma patients were included, of which 226 (26.9%) patients showed positive PD-L1 expression, and 5 (0.6%) patients showed high PD-L1 expression (TPS≥50%). This evidence concerns the gene CD274 and lung adenocarcinoma.